Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
73.21
+1.92 (2.69%)
Jun 3, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.02 billion as of June 3, 2026. Its market cap has increased by 205.71% in one year.
Market Cap
6.02B
Enterprise Value
4.56B
1-Year Change
205.71%
Ranking
Category
Stock Price
$73.21
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.02B, an increase of 621.65%. That is a compound annual growth rate of 40.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 5.86B | -5.79% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 7.46B |
| Vaxcyte | 7.42B |
| Immunovant | 6.84B |
| Celcuity | 6.48B |
| Protagonist Therapeutics | 6.40B |
| Spyre Therapeutics | 6.38B |
| Mirum Pharmaceuticals | 6.19B |
| Apogee Therapeutics | 6.16B |